FDA Approves Drug for Basal Cell Carcinoma
The US Food and Drug Administration (FDA) has approved the first drug specifically for basal cell carcinoma, the most common type of skin cancer. The drug is called vismodegib (Erivedge)
Non-melanoma Skin Cancer Linked to Risk of Other Cancers
A study published in the Journal of the National Cancer Institute found that people with a history of basal or squamous cell skin cancer (also known as non-melanoma skin cancer) were at an increased risk of developing other cancers later on.